Hepatotaxel is Glucuronolactone Tablets and Biphenyl Dibenzoate both have some therapeutic effect on hepatitis, but it is impossible to judge who is better with the medication, which varies from person to person. Glucuronolactone tablets have a protective and detoxifying effect on the liver and are suitable for the adjuvant treatment of acute and chronic hepatitis. The drug should be contraindicated in people who are allergic to the product. Occasional adverse reactions of redness of the face and gastrointestinal discomfort (mild) may occur after use of the drug, which disappears after dosage reduction or discontinuation of the drug. The drug should be contraindicated in people who are allergic to the product, people with cirrhosis of the liver, pregnant and lactating women. Possible adverse reactions after the use of the drug include dry mouth, mild nausea and skin rash. Glucuronolactone tablets and biphenyldiphenyl are both hepatoprotective and enzyme-lowering, and have a certain therapeutic effect on hepatitis, but in view of the individual variability of the groups who use the two drugs, with different outcomes, it is impossible to judge whose efficacy is better. The use of specific drugs should be carried out under the guidance of specialists, and should not be used without authorization.